Heterogeneity at the invasion front of triple negative breast cancer cells

Identifying better predictive and prognostic biomarkers for the diagnosis and treatment of triple negative breast cancer (TNBC) is complicated by tumor heterogeneity ranging from responses to therapy, mutational burden, and clonal evolution. To overcome the gap in our understanding of tumor heteroge...

Descripción completa

Detalles Bibliográficos
Autores principales: Aw Yong, Koh Meng, Ulintz, Peter J., Caceres, Sara, Cheng, Xu, Bao, Liwei, Wu, Zhifen, Jiagge, Evelyn M., Merajver, Sofia D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113246/
https://www.ncbi.nlm.nih.gov/pubmed/32238832
http://dx.doi.org/10.1038/s41598-020-62516-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113246/
https://www.ncbi.nlm.nih.gov/pubmed/32238832
http://dx.doi.org/10.1038/s41598-020-62516-8

Ejemplares similares